This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Fuji Yakuhin Co., Ltd. Active years: 2013-2020.
Company Filing History:
Years Active: 2013-2020
Title: Seiichi Kobashi: Innovator in Pharmaceutical Chemistry
Introduction
Seiichi Kobashi is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents, his work has garnered attention in the scientific community.
Latest Patents
Kobashi's latest patents include innovative formulations and methods. One of his notable inventions is a crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole. This type II crystal exhibits characteristic peaks at specific diffraction angles, which are crucial for its identification and application. Another significant patent involves a bisphosphonic acid compound designed to inhibit ectopic calcification. This compound shows promise in pharmaceutical compositions aimed at treating various conditions.
Career Highlights
Seiichi Kobashi is associated with Fuji Yakuhin Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating compounds that address critical health issues, showcasing his dedication to improving patient outcomes.
Collaborations
Kobashi has collaborated with esteemed colleagues, including Junichiro Uda and Naoki Ashizawa. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic solutions.
Conclusion
Seiichi Kobashi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the development of effective treatments, underscoring the importance of innovation in healthcare.